From: Design and analysis of outcomes following SARS-CoV-2 infection in veterans
Variable Name | COVID-19 (n = 208,536) | Uninfected (n = 5,173,400) | SMD |
---|---|---|---|
Age, mean (SD) | 60.6 (16.2) | 60.6 (16.4) | 0.00106 |
BMI, mean (SD) | 31.3 (6.4) | 31.3 (6.6) | 0.01178 |
Sex, N (%) | |||
Female | 21,949 (10.5) | 540,127 (10.4) | 0.00988 |
Male | 183,676 (88.1) | 4,566,632 (88.3) | |
Unknown | 2,911 (1.4) | 66,641 (1.3) | |
Race, N (%) | |||
American Indian/Alaska Native | 1,965 (0.9) | 47,784 (0.9) | 0.00610 |
Asian | 2,081 (1.0) | 51,718 (1.0) | |
Black or African American | 47,726 (22.9) | 1,189,212 (23.0) | |
Native Hawaiian or Other Pacific Islander | 1,946 (0.9) | 48,095 (0.9) | |
White | 139,952 (67.1) | 3,474,658 (67.2) | |
Multiple Races | 1,978 (0.9) | 49,028 (0.9) | |
Missing | 12,888 (6.2) | 312,905 (6.0) | |
Hispanic Ethnicity, N (%) | |||
Yes | 20,309 (9.7) | 492,607 (9.5) | 0.00792 |
No | 181,097 (86.8) | 4,506,252 (87.1) | |
Missing | 7,130 (3.4) | 174,541 (3.4) | |
Rurality, N (%) | |||
Urban | 149,310 (71.6) | 3,700,754 (71.5) | 0.00144 |
Not Urban (incl. missing) | 59,226 (28.4) | 1,472,646 (28.5) | |
Smoking Status, N (%) | |||
Current | 26,188 (12.6) | 654,415 (12.6) | 0.01379 |
Former | 88,275 (42.3) | 2,201,135 (42.5) | |
Never | 81,916 (39.3) | 2,032,442 (39.3) | |
Missing | 12,157 (5.8) | 285,408 (5.5) | |
CDC High Risk Conditions, N (%) | |||
Coronary Heart Disease | 59,972 (28.8) | 1,472,173 (28.5) | 0.00668 |
Cancer | 38,136 (18.3) | 942,791 (18.2) | 0.00165 |
Chronic Kidney Disease | 47,610 (22.8) | 1,161,200 (22.4) | 0.00920 |
Congestive Heart Failure | 22,124 (10.6) | 532,106 (10.3) | 0.01059 |
Pulmonary | 46,178 (22.1) | 1,131,201 (21.9) | 0.00671 |
Dementia | 10,837 (5.2) | 254,136 (4.9) | 0.01298 |
Diabetes | 72,020 (34.5) | 1,773,699 (34.3) | 0.00528 |
Hypertension | 127,761 (61.3) | 3,174,235 (61.4) | 0.00187 |
Liver Disease | 15,324 (7.3) | 370,974 (7.2) | 0.00684 |
Sickle Cell | 383 (0.2) | 9,131 (0.2) | 0.00169 |
Transplant | 687 (0.3) | 16,864 (0.3) | 0.00061 |
Stroke/Cerebrovascular disease | 13,012 (6.2) | 314,234 (6.1) | 0.00689 |
Substance Use Disorder | 25,915 (12.4) | 645,302 (12.5) | 0.00140 |
Anxiety | 47,186 (22.6) | 1,165,628 (22.5) | 0.00230 |
Bipolar disorder | 8,039 (3.9) | 199,388 (3.9) | 0.00005 |
Major Depression | 67,383 (32.3) | 1,664,825 (32.2) | 0.00282 |
PTSD | 52,964 (25.4) | 1,317,278 (25.5) | 0.00148 |
Schizophrenia | 4,737 (2.3) | 115,145 (2.2) | 0.00309 |
# CDC High Risk Conditions, mean (SD) | 2.3 (1.9) | 2.3 (1.9) | 0.01088 |
# Mental Health Conditions (Anxiety, Bipolar disorder, major depression, PTSD, schizophrenia), mean (SD) | 0.9 (1.1) | 0.9 (1.0) | 0.00200 |
Gagne score, mean (SD) | 1.4 (2.3) | 1.4 (2.2) | 0.01559 |
# VA Inpatient Admissions, mean (SD) | 0.4 (1.2) | 0.4 (1.3) | 0.00079 |
# VA Primary Care Visits, mean (SD) | 8.6 (9.7) | 8.3 (10.2) | 0.02916 |
# VA Specialty Care Visits, mean (SD) | 13.9 (14.1) | 13.4 (14.9) | 0.03288 |
Mental Health Care Utilization, mean (SD) | 7.9 (22.6) | 7.8 (21.9) | 0.00457 |
Immunosuppressed in prior 24 months, N (%) | 20,366 (9.8) | 502,358 (9.7) | 0.00188 |
CLC At Index Date, N (%) | 2,176 (1.0) | 46,586 (0.9) | 0.01457 |
NOSOS score, N (%) | |||
NOSOS, missing | 4,801 (2.3) | 110,729 (2.1) | 0.03224 |
NOSOS Category 1 [0, 0.417) | 5,708 (2.7) | 129,206 (2.5) | |
NOSOS Category 2 [0.417, 0.471) | 9,599 (4.6) | 227,788 (4.4) | |
NOSOS Category 3 [0.471, 0.534) | 12,449 (6.0) | 305,685 (5.9) | |
NOSOS Category 4 [0.534, 0.611) | 15,187 (7.3) | 378,825 (7.3) | |
NOSOS Category 5 [0.611, 0.707) | 17,737 (8.5) | 450,045 (8.7) | |
NOSOS Category 6 [0.707, 0.829) | 20,556 (9.9) | 525,057 (10.1) | |
NOSOS Category 7 [0.829, 0.998) | 23,462 (11.3) | 599,981 (11.6) | |
NOSOS Category 8 [0.998, 1.259) | 26,956 (12.9) | 686,219 (13.3) | |
NOSOS Category 9 [1.259, 1.805) | 31,372 (15.0) | 786,826 (15.2) | |
NOSOS Category 10 [1.805, Inf) | 40,709 (19.5) | 973,039 (18.8) | |
CAN Score, N (%) | |||
CAN, missing | 4,066 (1.9) | 86,041 (1.7) | 0.03258 |
CAN Category 1, 0–20 | 34,427 (16.5) | 851,737 (16.5) | |
CAN Category 2, 25–40 | 31,926 (15.3) | 801,677 (15.5) | |
CAN Category 3, 45–60 | 38,266 (18.3) | 970,378 (18.8) | |
CAN Category 4, 65–80 | 46,894 (22.5) | 1,184,134 (22.9) | |
CAN Category 5, 85–90 | 30,745 (14.7) | 762,537 (14.7) | |
CAN Category 6, 95–99 | 22,212 (10.7) | 516,896 (10.0) | |
Vaccinated in January-April 2021, N (%) | 3,153 (1.5) | 75,353 (1.5) | 0.00470 |
Index Month, N (%) | |||
March 2020 | 2,340 (1.1) | 58,278 (1.1) | 0.00363 |
April 2020 | 6,786 (3.3) | 168,727 (3.3) | |
May 2020 | 4,402 (2.1) | 109,604 (2.1) | |
June 2020 | 6,967 (3.3) | 173,776 (3.4) | |
July 2020 | 14,945 (7.2) | 373,025 (7.2) | |
August 2020 | 8,376 (4.0) | 208,750 (4.0) | |
September 2020 | 6,787 (3.3) | 169,048 (3.3) | |
October 2020 | 12,212 (5.9) | 302,119 (5.8) | |
November 2020 | 31,004 (14.9) | 767,646 (14.8) | |
December 2020 | 43,732 (21.0) | 1,085,816 (21.0) | |
January 2021 | 36,282 (17.4) | 900,381 (17.4) | |
February 2021 | 15,699 (7.5) | 388,553 (7.5) | |
March 2021 | 9,942 (4.8) | 244,839 (4.7) | |
April 2021 | 9,062 (4.3) | 222,838 (4.3) | |
U.S. State of Residence, N (%) | |||
Alaska | 694 (0.3) | 16,880 (0.3) | 0.01515 |
Alabama | 4,089 (2.0) | 101,648 (2.0) | |
Arkansas | 3,075 (1.5) | 76,426 (1.5) | |
Arizona | 6,310 (3.0) | 157,105 (3.0) | |
California | 16,253 (7.8) | 405,136 (7.8) | |
Colorado | 3,278 (1.6) | 80,733 (1.6) | |
Connecticut | 1,895 (0.9) | 46,782 (0.9) | |
Washington, D.C. | 414 (0.2) | 10,111 (0.2) | |
Delaware | 552 (0.3) | 13,199 (0.3) | |
Florida | 16,003 (7.7) | 399,175 (7.7) | |
Georgia | 7,893 (3.8) | 196,375 (3.8) | |
Hawaii | 263 (0.1) | 6,295 (0.1) | |
Iowa | 2,473 (1.2) | 59,479 (1.1) | |
Idaho | 1,582 (0.8) | 39,124 (0.8) | |
Illinois | 6,462 (3.1) | 159,840 (3.1) | |
Indiana | 4,533 (2.2) | 112,806 (2.2) | |
Kansas | 2,471 (1.2) | 61,282 (1.2) | |
Kentucky | 3,352 (1.6) | 82,956 (1.6) | |
Louisiana | 3,754 (1.8) | 93,423 (1.8) | |
Massachusetts | 2,990 (1.4) | 73,840 (1.4) | |
Maryland | 2,640 (1.3) | 65,047 (1.3) | |
Maine | 631 (0.3) | 15,442 (0.3) | |
Michigan | 4,383 (2.1) | 108,714 (2.1) | |
Minnesota | 4,251 (2.0) | 105,503 (2.0) | |
Missouri | 6,609 (3.2) | 164,281 (3.2) | |
Mississippi | 1,804 (0.9) | 44,823 (0.9) | |
Montana | 1,122 (0.5) | 27,824 (0.5) | |
North Carolina | 8,521 (4.1) | 212,232 (4.1) | |
North Dakota | 865 (0.4) | 21,154 (0.4) | |
Nebraska | 1,872 (0.9) | 46,270 (0.9) | |
New Hampshire | 743 (0.4) | 18,024 (0.3) | |
New Jersey | 2,623 (1.3) | 64,850 (1.3) | |
New Mexico | 1,373 (0.7) | 34,024 (0.7) | |
Nevada | 3,049 (1.5) | 75,467 (1.5) | |
New York | 7,739 (3.7) | 192,659 (3.7) | |
Ohio | 9,173 (4.4) | 228,564 (4.4) | |
Oklahoma | 4,030 (1.9) | 100,147 (1.9) | |
Oregon | 1,386 (0.7) | 34,259 (0.7) | |
Pennsylvania | 7,880 (3.8) | 196,104 (3.8) | |
Rhode Island | 762 (0.4) | 18,729 (0.4) | |
South Carolina | 6,352 (3.0) | 157,970 (3.1) | |
South Dakota | 1,408 (0.7) | 29,278 (0.6) | |
Tennessee | 5,848 (2.8) | 145,295 (2.8) | |
Texas | 19,436 (9.3) | 485,224 (9.4) | |
Utah | 1,243 (0.6) | 30,706 (0.6) | |
Virginia | 5,070 (2.4) | 125,759 (2.4) | |
Vermont | 149 (0.1) | 3,594 (0.1) | |
Washington | 1,976 (0.9) | 48,855 (0.9) | |
Wisconsin | 5,087 (2.4) | 126,171 (2.4) | |
West Virginia | 1,621 (0.8) | 40,213 (0.8) | |
Wyoming | 554 (0.3) | 13,603 (0.3) | |
Distance to Nearest VAMC (miles), mean (SD) | 35.6 (36.5) | 35.8 (35.1) | 0.00452 |